Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
MeaCor Logo
MeaCor Growth Score
48
CB Rank
68491
Heat Score
59
MeaCor develops novel transcatheter devices for the treatment of heart disease.
Founded
obfuscation
PrivateSeries A Ayer, Massachusetts, United States1-10 meacor.com/
Health Care
Medical Device
Overview

MeaCor
Total Funding
obfuscation
Growth Score
48
Heat Score
59

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score48
-1 pts
in past quarter
Heat Score 59
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About MeaCor

CB Rank
68491
MeaCor develops novel transcatheter devices for the treatment of heart disease.
Founded
obfuscation
PrivateSeries A Ayer, Massachusetts, United States1-10 meacor.com/
Health Care
Medical Device

Funding Rounds

Series A
OBF
in
obfuscation
Non-equity Assistance
OBF
in
obfuscation

Details

Legal Name MeaCor Inc.
Operating Status Active
Company Type For Profit
About the Company
MeaCor develops novel transcatheter devices for the treatment of heart disease.
Predictions & Insights

Growth Insight

See this Growth Insight
MeaCor is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

CryoCinch
A transcatheter anchoring system designed for mitral and tricuspid valve repair, utilizing cryoadhesion for heart motion compensation.

Research & Development

MeaCor is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A
obfuscation
Series A - MeaCor Logo
Series A - MeaCor
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News

News and Press

News•May 15, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

488
-22.29%
 in past month

IT Spend

$71KThis year, MeaCor is projected to spend $71K on IT, according to Aberdeen.

Active Website Tech Count

2MeaCor is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  SPF.

Total IP

11The intellectual property of MeaCor includes 11 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is MeaCor's headquarters? MeaCor is located in Ayer, Massachusetts, United States.Who invested in MeaCor? MeaCor is funded by MedTech Innovator.When was the last funding round for MeaCor? MeaCor closed its last funding round on
obfuscation
from a Series A round.Who are MeaCor's competitors? Alternatives and possible competitors to MeaCor may include Abbott, Medtronic, and  JenaValve Technology.How much funding has MeaCor raised to date? MeaCor has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|